Price T Rowe Associates Inc Novavax Inc Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Novavax Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 90,223 shares of NVAX stock, worth $767,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,223

Previous 72,556 24.35%

Holding current value

$767,797

Previous $919,000 24.05%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $189,213 - $302,282	17,667 Added 24.35%	90,223 $1.14 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $64,149 - $345,816	16,491 Added 29.41%	72,556 $919,000
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $30,561 - $48,930	8,128 Added 16.96%	56,065 $269,000
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $25,238 - $40,328	-5,258 Reduced 9.88%	47,937 $231,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $1,375 - $1,967	202 Added 0.38%	53,195 $386,000
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $32,269 - $46,057	-4,838 Reduced 8.37%	52,993 $394,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $67,351 - $145,928	11,693 Added 25.34%	57,831 $401,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $4,917 - $13,897	555 Added 1.22%	46,138 $474,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $45,008 - $188,244	2,473 Added 5.74%	45,583 $830,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $42,338 - $87,863	-1,167 Reduced 2.64%	43,110 $2.22 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $12.1 Million - $24.7 Million	-173,080 Reduced 79.63%	44,277 $3.26 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $33.4 Million - $54.2 Million	-248,562 Reduced 53.35%	217,357 $31.1 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $13.5 Million - $20.6 Million	76,195 Added 19.55%	465,919 $96.6 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $52.4 Million - $112 Million	-433,044 Reduced 52.63%	389,724 $82.7 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $53.9 Million - $153 Million	476,750 Added 137.78%	822,768 $149 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $27.2 Million - $48.3 Million	346,018 New	346,018 $38.6 Million

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Novavax Inc Transaction History